Abstract Background: Preventive interventions in the form of parenting support can reduce the risk of mental disorders in children. Summarising…
Abstract Background: We investigated whether the associations of state medical and recreational cannabis legalization (MCL, RCL enactment) with increasing prevalence…
Abstract Objective: This systematic review examines psychiatric medications approved by the FDA for anxiety disorders, post-traumatic stress disorder (PTSD) and…
Abstract Background: Anxiety disorders (ADs) are a complex group of mental disorders and majorly contribute to the global health-related burden.…
Abstract Introduction: Preclinical and clinical evidence has elucidated that cannabis-based medical formulations (CBMFs) may display anxiolytic, antidepressive, and neuroprotective properties.…
Abstract Background: Benzodiazepines (BZDs) are widely prescribed for anxiety disorders. However, the long-term implications on mental health remain uncertain, especially…
Abstract Although preliminary evidence suggests Cannabis’s efficacy in symptom control for anxiety and depression—psychiatric disorders that significantly impact mental health—much…
Abstract Background: An increasing number of countries have or are considering legalizing cannabis. One concern is that legalization of cannabis…
Abstract Objective: The comorbidity of alcohol and substance use disorders among persons with bipolar disorder is elevated, as indicated by…
Abstract Objective: Evidence is accumulating that components of the Cannabis sativa plant may have therapeutic potential in treating psychiatric disorders.…